vs

Side-by-side financial comparison of CONSUMER PORTFOLIO SERVICES, INC. (CPSS) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

CONSUMER PORTFOLIO SERVICES, INC. is the larger business by last-quarter revenue ($109.4M vs $87.2M, roughly 1.3× Schrodinger, Inc.). Schrodinger, Inc. runs the higher net margin — 37.3% vs 4.6%, a 32.7% gap on every dollar of revenue. On growth, CONSUMER PORTFOLIO SERVICES, INC. posted the faster year-over-year revenue change (3.9% vs -1.2%). CONSUMER PORTFOLIO SERVICES, INC. produced more free cash flow last quarter ($288.3M vs $-16.1M). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs 9.2%).

Consumer Portfolio Services, Inc. is a U.S. specialty finance firm providing indirect auto loan financing and servicing for consumers with limited or subprime credit. It partners with franchised and independent car dealerships nationwide to originate installment contracts for new and used vehicle purchases.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

CPSS vs SDGR — Head-to-Head

Bigger by revenue
CPSS
CPSS
1.3× larger
CPSS
$109.4M
$87.2M
SDGR
Growing faster (revenue YoY)
CPSS
CPSS
+5.1% gap
CPSS
3.9%
-1.2%
SDGR
Higher net margin
SDGR
SDGR
32.7% more per $
SDGR
37.3%
4.6%
CPSS
More free cash flow
CPSS
CPSS
$304.4M more FCF
CPSS
$288.3M
$-16.1M
SDGR
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
9.2%
CPSS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPSS
CPSS
SDGR
SDGR
Revenue
$109.4M
$87.2M
Net Profit
$5.0M
$32.5M
Gross Margin
65.7%
Operating Margin
6.6%
-19.7%
Net Margin
4.6%
37.3%
Revenue YoY
3.9%
-1.2%
Net Profit YoY
-3.2%
180.8%
EPS (diluted)
$0.21
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPSS
CPSS
SDGR
SDGR
Q4 25
$109.4M
$87.2M
Q3 25
$108.4M
$54.3M
Q2 25
$109.8M
$54.8M
Q1 25
$106.9M
$59.6M
Q4 24
$105.3M
$88.3M
Q3 24
$100.6M
$35.3M
Q2 24
$95.9M
$47.3M
Q1 24
$91.7M
$36.6M
Net Profit
CPSS
CPSS
SDGR
SDGR
Q4 25
$5.0M
$32.5M
Q3 25
$4.9M
$-32.8M
Q2 25
$4.8M
$-43.2M
Q1 25
$4.7M
$-59.8M
Q4 24
$5.1M
$-40.2M
Q3 24
$4.8M
$-38.1M
Q2 24
$4.7M
$-54.0M
Q1 24
$4.6M
$-54.7M
Gross Margin
CPSS
CPSS
SDGR
SDGR
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Q1 24
51.6%
Operating Margin
CPSS
CPSS
SDGR
SDGR
Q4 25
6.6%
-19.7%
Q3 25
6.5%
-84.6%
Q2 25
6.3%
-96.6%
Q1 25
6.4%
-85.5%
Q4 24
7.0%
-23.5%
Q3 24
6.8%
-193.9%
Q2 24
7.0%
-111.4%
Q1 24
7.1%
-184.3%
Net Margin
CPSS
CPSS
SDGR
SDGR
Q4 25
4.6%
37.3%
Q3 25
4.5%
-60.4%
Q2 25
4.4%
-78.8%
Q1 25
4.4%
-100.4%
Q4 24
4.9%
-45.5%
Q3 24
4.8%
-108.1%
Q2 24
4.9%
-114.2%
Q1 24
5.0%
-149.5%
EPS (diluted)
CPSS
CPSS
SDGR
SDGR
Q4 25
$0.21
$0.45
Q3 25
$0.20
$-0.45
Q2 25
$0.20
$-0.59
Q1 25
$0.19
$-0.82
Q4 24
$0.21
$-0.55
Q3 24
$0.20
$-0.52
Q2 24
$0.19
$-0.74
Q1 24
$0.19
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPSS
CPSS
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$6.3M
$395.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$309.5M
$364.1M
Total Assets
$3.9B
$726.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPSS
CPSS
SDGR
SDGR
Q4 25
$6.3M
$395.5M
Q3 25
$9.4M
$391.2M
Q2 25
$15.8M
$450.2M
Q1 25
$29.8M
$500.3M
Q4 24
$11.7M
$352.1M
Q3 24
$8.1M
$388.7M
Q2 24
$9.8M
$377.3M
Q1 24
$13.2M
$431.1M
Stockholders' Equity
CPSS
CPSS
SDGR
SDGR
Q4 25
$309.5M
$364.1M
Q3 25
$307.6M
$321.4M
Q2 25
$303.1M
$342.9M
Q1 25
$298.4M
$373.5M
Q4 24
$292.8M
$421.4M
Q3 24
$285.1M
$449.4M
Q2 24
$280.3M
$474.0M
Q1 24
$279.1M
$513.7M
Total Assets
CPSS
CPSS
SDGR
SDGR
Q4 25
$3.9B
$726.2M
Q3 25
$3.8B
$653.7M
Q2 25
$3.8B
$688.2M
Q1 25
$3.7B
$743.0M
Q4 24
$3.5B
$823.2M
Q3 24
$3.5B
$669.3M
Q2 24
$3.3B
$688.4M
Q1 24
$3.0B
$737.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPSS
CPSS
SDGR
SDGR
Operating Cash FlowLast quarter
$289.0M
$-16.1M
Free Cash FlowOCF − Capex
$288.3M
$-16.1M
FCF MarginFCF / Revenue
263.5%
-18.5%
Capex IntensityCapex / Revenue
0.6%
0.0%
Cash ConversionOCF / Net Profit
58.02×
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$500.9M
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPSS
CPSS
SDGR
SDGR
Q4 25
$289.0M
$-16.1M
Q3 25
$84.9M
$-61.9M
Q2 25
$54.5M
$-52.2M
Q1 25
$73.9M
$144.1M
Q4 24
$233.8M
$-31.1M
Q3 24
$69.8M
$-33.3M
Q2 24
$43.3M
$-53.7M
Q1 24
$52.7M
$-39.3M
Free Cash Flow
CPSS
CPSS
SDGR
SDGR
Q4 25
$288.3M
$-16.1M
Q3 25
$84.9M
$-62.4M
Q2 25
$54.3M
$-52.5M
Q1 25
$73.4M
$143.5M
Q4 24
$233.3M
$-32.0M
Q3 24
$69.7M
$-34.6M
Q2 24
$43.1M
$-54.7M
Q1 24
$52.6M
$-43.4M
FCF Margin
CPSS
CPSS
SDGR
SDGR
Q4 25
263.5%
-18.5%
Q3 25
78.3%
-114.8%
Q2 25
49.5%
-95.9%
Q1 25
68.7%
240.9%
Q4 24
221.6%
-36.2%
Q3 24
69.3%
-98.0%
Q2 24
45.0%
-115.6%
Q1 24
57.3%
-118.5%
Capex Intensity
CPSS
CPSS
SDGR
SDGR
Q4 25
0.6%
0.0%
Q3 25
0.0%
0.9%
Q2 25
0.1%
0.6%
Q1 25
0.4%
1.0%
Q4 24
0.4%
1.0%
Q3 24
0.1%
3.8%
Q2 24
0.2%
2.1%
Q1 24
0.1%
11.2%
Cash Conversion
CPSS
CPSS
SDGR
SDGR
Q4 25
58.02×
-0.50×
Q3 25
17.50×
Q2 25
11.35×
Q1 25
15.74×
Q4 24
45.43×
Q3 24
14.55×
Q2 24
9.27×
Q1 24
11.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPSS
CPSS

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons